Topiramate Extended Release Generic

Quote
anonymous said:
yeah, I forgot about your vast Pharma experience that covers clinical trials, regulatory, commercialization and M&A.

you were hired to sell a molecule, not a platform.

the molecule was approved in the quickest, least risky and least costly way possible to avoid over burdening the company with costs that needed to be recouped.

Do you have any idea how much clinical studies cost? Even IITs cost millions and only provide anecdotal data that likely won’t meet your high standards.

if you want a new molecule that is going to have new data every year or so, you are and have been at the wrong company. The fact that you are still here making excuses is a good indicator no one else will take you.

Ow quit bitching and sell.
Click to expand...

go back to sending pointless/ made up success stories.
 






come on y’all we tried to get you more data but the study did not pan out. Y’all are lost as last years easter egg -we got all the juice we could out of TXR. Don’t piss on my leg and tell me it’s raining. I am as nervous as a long tailed cat in a room full of rocking chairs about our near term future.
 






anonymous said:
come on y’all we tried to get you more data but the study did not pan out. Y’all are lost as last years easter egg -we got all the juice we could out of TXR. Don’t piss on my leg and tell me it’s raining. I am as nervous as a long tailed cat in a room full of rocking chairs about our near term future.
Click to expand...

Amazing! That is some funny ass chit.
 






anonymous said:
listen Sally, a new detail piece and new messaging isn’t going to help you overcome the fact that you are an excuse maker.

congratulations, you have picked off the low hanging fruit in the generic topiramate space giving you a whopping 4-5% share of topiramate use.

maybe now is the time to use those selling skills you think you possess and convert some business.

if all you want is for other people to make things easy for you, you aren’t really bringing much to the table.
Click to expand...


The Chad can become so immune to their own stories that they can convince themselves that the lies are true.
 






What happened to this product? It’s not in pharmacies. Did Zydus decide not to manufactor and sell generic Extende Release Topiramate? Did Supernus dodge a huge bullet and nobody is talking about it? I can’t figure it out
 






Good question. Where are all the “experts” from a few months ago who were telling us we were all doomed and “we are being lied to”?
Same place they went when they said there would definitely be lay-offs this spring and the same place they went when they trashed the USWM deal last week I guess. Probably just me but I am starting to wonder if they were ever really experts at all. Maybe it’s time for me to look for what’s really going on through sources that are not anonymous or something
 






anonymous said:
Good question. Where are all the “experts” from a few months ago who were telling us we were all doomed and “we are being lied to”?
Same place they went when they said there would definitely be lay-offs this spring and the same place they went when they trashed the USWM deal last week I guess. Probably just me but I am starting to wonder if they were ever really experts at all. Maybe it’s time for me to look for what’s really going on through sources that are not anonymous or something
Click to expand...

Management even addressed this at POA. I think it was a legitimate issue but what happened. Where’s the drug now
 






anonymous said:
Good question. Where are all the “experts” from a few months ago who were telling us we were all doomed and “we are being lied to”?
Same place they went when they said there would definitely be lay-offs this spring and the same place they went when they trashed the USWM deal last week I guess. Probably just me but I am starting to wonder if they were ever really experts at all. Maybe it’s time for me to look for what’s really going on through sources that are not anonymous or something
Click to expand...

Listen, that train is coming its just a matter of time. You and I both know it.

What company would want to launch a product during this pandemic. Product should be here by July. ​
 






Listen you don’t launch a generic. You put it in the pipeline And watch it get switched out at the pharmacy. I can’t believe how little of a standard people on here hold themselves to. You literally know nothing about what you are talking about but that doesn’t stop you for throwing random shit out there like it’s fact. It’s like you come here to make yourself feel good about yourself or important or something.
 






anonymous said:
Listen you don’t launch a generic. You put it in the pipeline And watch it get switched out at the pharmacy. I can’t believe how little of a standard people on here hold themselves to. You literally know nothing about what you are talking about but that doesn’t stop you for throwing random shit out there like it’s fact. It’s like you come here to make yourself feel good about yourself or important or something.
Click to expand...

But here we sit with you continuing to feel the
need to respond. You are pathetic.
 




































I’m not sure how but it appears Supernus has dodged the biggest bullet we have faced in the generic topiramate ER release. Although the Qudexy XR patent expired in March of this year Zydus has not started selling generic topiramate XR into the market. Congrats all around
 






anonymous said:
I’m not sure how but it appears Supernus has dodged the biggest bullet we have faced in the generic topiramate ER release. Although the Qudexy XR patent expired in March of this year Zydus has not started selling generic topiramate XR into the market. Congrats all around
Click to expand...

I'm sure we made some side deal with Zydus to have exclusive right to promote a generic TXR 6 months before anyone else. If something was done to delay the AG great job Supernus!!
 






Top Bottom
Back
Quote